Business
Roche Acquires PathAI for $750 Million
Pharmaceutical giant Roche has acquired AI company PathAI for $750 million to enhance its use of artificial intelligence in disease diagnosis. The deal aims to speed up the pathologists' work and improve overall diagnostic accuracy.
Coverage timeline — 1 article
STAT News
Roche has signed a deal to acquire PathAI to speed up its use of artificial intelligence to help pathologists diagnose diseases.
2026-05-08 19:29 UTC